Cancer Chemotherapy via Natural Bioactive Compounds. 2022

Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India.

Cancer-induced mortality is increasingly prevalent globally, which skyrocketed the necessity to discover new/novel, safe and effective anticancer drugs. Cancer is characterized by the continuous multiplication of cells in the human, which is unable to control. Scientific research is drawing its attention toward naturally-derived bioactive compounds as they have fewer side effects compared to the current synthetic drugs used for chemotherapy. Drugs isolated from natural sources and their role in the manipulation of epigenetic markers in cancer are discussed briefly in this review article. With advancing medicinal plant biotechnology and microbiology in the past century, several anticancer phytomedicines were developed. Modern pharmacopeia contains at least 25% herbal-based remedies, including clinically used anticancer drugs. These drugs mainly include the podophyllotoxin derivatives vinca alkaloids, curcumin, mistletoe plant extracts, taxanes, camptothecin, combretastatin, and colchicine artesunate, homoharringtonine, ellipticine, roscovitine, maytansine, tapsigargin,and bruceantin. Compounds (psammaplin, didemnin, dolastin, ecteinascidin, and halichondrin) isolated from marine sources and animals such as microalgae, cyanobacteria, heterotrophic bacteria, invertebrates. They have been evaluated for their anticancer activity on cells and experimental animal models and used chemotherapy.Drug-induced manipulation of epigenetic markers plays an important role in the treatment of cancer. The development of a new drug from isolated bioactive compounds of plant sources has been a feasible way to lower the toxicity and increase their effectiveness against cancer. Potential anticancer therapeutic leads obtained from various ethnomedicinal plants, foods, marine, and microorganisms are showing effective yet realistically safe pharmacological activity. This review will highlight important plant-based bioactive compounds like curcumin, stilbenes, terpenes, other polyphenolic phyto-compounds, and structurally related families that are used to prevent/ ameliorate cancer. However, a contribution from all possible fields of science is still a prerequisite for discovering safe and effective anticancer drugs.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D003474 Curcumin A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-,Curcumin Phytosome,Diferuloylmethane,Mervia,Turmeric Yellow,Phytosome, Curcumin,Yellow, Turmeric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural

Related Publications

Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
January 2017, Frontiers in pharmacology,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
November 2019, Biomolecules,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
January 2014, BioMed research international,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
January 2010, Journal of pharmaceutical and biomedical analysis,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
March 2024, Fitoterapia,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
January 2009, Current pharmaceutical design,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
January 2014, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
September 2018, Pharmacological research,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
April 2024, Analytical and bioanalytical chemistry,
Kalyani Pathak, and Manash P Pathak, and Riya Saikia, and Urvashee Gogoi, and Jon J Sahariah, and James H Zothantluanga, and Abhishek Samanta, and Aparoop Das
January 2017, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!